Back

Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

29 August 2020 (08:40 - 08:50)
Organised by:
Congress Presentation Part of: Deep Dive in Acute Coronary Syndromes Inflammation ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Philippe L'Allier

Montreal Heart Institute, Montreal (Canada)

2 More presentations in this session

Presentation thumbnail
Diagnostic impact of early cardiac magnetic resonance imaging in patients with the working diagnosis of MINOCA. Does the final diagnosis affect patients outcome?
Doctor H. Vago (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
The Gly82Ser polymorphism in the receptor for advanced glycation end products is associated with increased risk for coronary events in the general population
Mrs H. Grauen Larsen (Malmo, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Deep Dive in Acute Coronary Syndromes

The Event

Event poster

ESC Congress 2020

29 August 2020 08:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources